PCSK9-IN-11 |
| Catalog No.GC69671 |
PCSK9-IN-11 (compuesto 5r) is an orally effective PCSK9 inhibitor. PCSK9-IN-11 shows PCSK9 transcriptional inhibition activity in HepG2 cells, with an IC50 of 5.7 μM. PCSK9-IN-11 increases LDL receptor (LDLR) protein levels. PCSK9-IN-11 can be used for atherosclerosis research.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for PCSK9-IN-11
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for PCSK9-IN-11
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *